BioAgilytix and Sword Bio have announced a partnership to improve the offering of bioanalytical services from BioAgilytix, to include an immunoassay detection platform from Sword Bio. The collaboration is expected to meet the growing demand for the enhancement of the performance of immunoassays used for biomarkers, immunogenicity, and pharmacokinetics.

[EPISODE 25] Adam Stasio Talks, Large Data Sets, Breaking Down Problems, and Tech-Driven Solutions
On this episode of Molecular Moments, Jim McNally, Ph.D., speaks with Adam Stasio, president of SciMed, whose mission is to